Oxidative Stress-mediated Effects of Angiotensin II in the Cardiovascular System

Overview

Journal World J Hypertens

Date 2014 Mar 4

PMID 24587981

Citations 44

Authors

Hairuo Wen

Judith K Gwathmey

Lai-Hua Xie

Affiliations

Soon will be listed here.

Abstract

Angiotensin II (Ang II), an endogenous peptide hormone, plays critical roles in the pathophysiological modulation of cardiovascular functions. Ang II is the principle effector of the renin-angiotensin system for maintaining homeostasis in the cardiovascular system, as well as a potent stimulator of NAD(P)H oxidase, which is the major source and primary trigger for reactive oxygen species (ROS) generation in various tissues. Recent accumulating evidence has demonstrated the importance of oxidative stress in Ang II-induced heart diseases. Here, we review the recent progress in the study on oxidative stress-mediated effects of Ang II in the cardiovascular system. In particular, the involvement of Ang II-induced ROS generation in arrhythmias, cell death/heart failure, ischemia/reperfusion injury, cardiac hypertrophy and hypertension are discussed. Ca/calmodulin-dependent protein kinase II is an important molecule linking Ang II, ROS and cardiovascular pathological conditions.

Citing Articles

Taurine Prevents Angiotensin II-Induced Human Endocardial Endothelium Morphological Remodeling and the Increase in Cytosolic and Nuclear Calcium and ROS.

Jacques D, Bkaily G Nutrients. 2024; 16(5).

PMID: 38474873 PMC: 10935038. DOI: 10.3390/nu16050745.

New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases.

Scarian E, Viola C, Dragoni F, Di Gerlando R, Rizzo B, Diamanti L Int J Mol Sci. 2024; 25(5).

PMID: 38473944 PMC: 10931808. DOI: 10.3390/ijms25052698.

Endothelial Dysfunction and Pregnant COVID-19 Patients with Thrombophilia: A Narrative Review.

Sekulovski M, Mileva N, Chervenkov L, Peshevska-Sekulovska M, Vasilev G, Vasilev G Biomedicines. 2023; 11(9).

PMID: 37760899 PMC: 10525846. DOI: 10.3390/biomedicines11092458.

Idiopathic pulmonary fibrosis (IPF): disease pathophysiology, targets, and potential therapeutic interventions.

Saha P, Talwar P Mol Cell Biochem. 2023; 479(9):2181-2194.

PMID: 37707699 DOI: 10.1007/s11010-023-04845-6.

Immune landscape and redox imbalance during neurological disorders in COVID-19.

Thakur A, Sharma V, Averbek S, Liang L, Pandya N, Kumar G Cell Death Dis. 2023; 14(9):593.

PMID: 37673862 PMC: 10482955. DOI: 10.1038/s41419-023-06102-6.

References

Montezano A, Burger D, Paravicini T, Chignalia A, Yusuf H, Almasri M . Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circ Res. 2010; 106(8):1363-73. PMC: 3119893. DOI: 10.1161/CIRCRESAHA.109.216036. View

Abdalla S, Lother H, Abdel-Tawab A, Quitterer U . The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem. 2001; 276(43):39721-6. DOI: 10.1074/jbc.M105253200. View

Bescond J, Bois P, Lenfant J . Characterization of an angiotensin-II-activated chloride current in rabbit sino-atrial cells. J Membr Biol. 1994; 140(2):153-61. DOI: 10.1007/BF00232903. View

Iwasaki Y, Nishida K, Kato T, Nattel S . Atrial fibrillation pathophysiology: implications for management. Circulation. 2011; 124(20):2264-74. DOI: 10.1161/CIRCULATIONAHA.111.019893. View

Goette A, Lendeckel U, Klein H . Signal transduction systems and atrial fibrillation. Cardiovasc Res. 2002; 54(2):247-58. DOI: 10.1016/s0008-6363(01)00521-1. View

Raz L, Zhang Q, Zhou C, Han D, Gulati P, Yang L . Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat. PLoS One. 2010; 5(9):e12606. PMC: 2935374. DOI: 10.1371/journal.pone.0012606. View

Saito Y, Berk B . Angiotensin II-mediated signal transduction pathways. Curr Hypertens Rep. 2002; 4(2):167-71. DOI: 10.1007/s11906-002-0042-1. View

Lavoie J, Sigmund C . Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system. Endocrinology. 2003; 144(6):2179-83. DOI: 10.1210/en.2003-0150. View

Yu H, Gao J, Wang H, Wymore R, Steinberg S, McKinnon D . Effects of the renin-angiotensin system on the current I(to) in epicardial and endocardial ventricular myocytes from the canine heart. Circ Res. 2000; 86(10):1062-8. DOI: 10.1161/01.res.86.10.1062. View

10.

Guo D, Sun Y, Hamet P, Inagami T . The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res. 2001; 11(3):165-80. DOI: 10.1038/sj.cr.7290083. View

11.

Obayashi K, Horie M, Xie L, Tsuchiya K, Kubota A, Ishida H . Angiotensin II inhibits protein kinase A-dependent chloride conductance in heart via pertussis toxin-sensitive G proteins. Circulation. 1997; 95(1):197-204. DOI: 10.1161/01.cir.95.1.197. View

12.

Timmermans P, Wong P, Chiu A, Herblin W, Benfield P, Carini D . Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993; 45(2):205-51. View

13.

Ramirez M, Zhao X, Schulman H, Brown J . The nuclear deltaB isoform of Ca2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes. J Biol Chem. 1998; 272(49):31203-8. DOI: 10.1074/jbc.272.49.31203. View

14.

Sil P, Sen S . Angiotensin II and myocyte growth: role of fibroblasts. Hypertension. 1997; 30(2 Pt 1):209-16. DOI: 10.1161/01.hyp.30.2.209. View

15.

Dostal D, Baker K . The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?. Circ Res. 1999; 85(7):643-50. DOI: 10.1161/01.res.85.7.643. View

16.

Li H, Li W, Gupta A, Mohler P, Anderson M, Grumbach I . Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. Am J Physiol Heart Circ Physiol. 2009; 298(2):H688-98. PMC: 2822565. DOI: 10.1152/ajpheart.01014.2009. View

17.

Katada J, Majima M . AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol. 2002; 136(4):484-91. PMC: 1573373. DOI: 10.1038/sj.bjp.0704731. View

18.

Lemarie C, Schiffrin E . The angiotensin II type 2 receptor in cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2009; 11(1):19-31. DOI: 10.1177/1470320309347785. View

19.

Urata H, Healy B, Stewart R, BUMPUS F, Husain A . Angiotensin II receptors in normal and failing human hearts. J Clin Endocrinol Metab. 1989; 69(1):54-66. DOI: 10.1210/jcem-69-1-54. View

20.

Laursen J, Rajagopalan S, Galis Z, Tarpey M, Freeman B, Harrison D . Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997; 95(3):588-93. DOI: 10.1161/01.cir.95.3.588. View